C3890568_NCI_CareLex | Knowledge4COVID-19

Property	Value
?:definition	A document describing the purpose and operation of the Independent Data Monitoring Committee (IDMC), which may be established by the sponsor to assess the progress of a clinical trial at intervals, the safety data and the critical efficacy endpoints, and to recommend to the sponsor whether to continue, modify or stop a trial. [Adapted from TMF-RM]
?:hasCUIAnnotation	<https://research.tib.eu/covid-19/entity/C3890568>
?:hasGeneratedBy	<https://research.tib.eu/covid-19/SourceName/NCI_CareLex>
?:type	<https://research.tib.eu/covid-19/vocab/AnnotationDefinition>

Metadata

Anon_0

<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>

<http://purl.org/net/provenance/ns#DataItem>

<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>

<http://www.w3.org/2004/03/trix/rdfg-1/Graph>

<http://xmlns.com/foaf/0.1/primaryTopic>

<https://research.tib.eu/covid-19/entity/C3890568_NCI_CareLex>

<http://xmlns.com/foaf/0.1/topic>

Anon_0

<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes>

<https://research.tib.eu/covid-19/data/entity/C3890568_NCI_CareLex>

<http://purl.org/net/provenance/ns#createdBy>

Anon_1 (more)

expand all